Heat latest Triangle biopharma to execute reverse stock split

On the heels of Argos Therapeutics (Nasdaq: ARGS) executing a one-for-twenty reverse stock split, another Durham-based biopharmaceutical company Heat Biologics (Nasdaq: HTBX) has undertaken a one-for-ten reverse stock split of its own. Heat’s reverse stock split – as in the case of Argos – comes after shares of the company had remained below $1 for the better part of 2017 and the beginning of 2018.  In a filing with the SEC, Heat stated that it “has until March 12, 2018 to regain compliance…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news